10 Best Pharma Patent Blogs and Websites in 2025
Pharma Patent Blogs
Here are 10 Best Pharma Patent Blogs you should follow in 2025. Subscribe in one place on FeedSpot Reader.
1. Patent Docs
Blog https://www.patentdocs.org/ + Follow Blog
Patent Docs is a weblog authored by patent practitioners, which focuses on biotech/pharma patent law, including reports on changes in USPTO rules and procedures, recent court decisions, newly filed patent litigation, and recently issued patents.MORE Email ****@mbhb.com
Facebook Followers 208Twitter Followers 1.5K Since Oct 2006 Domain Authority 51 Read Now Get Email Contact Get Influential Bloggers ContactsGet access to 250k active Bloggers in 1500 niche categories.Get targeted media contact list in your niche at your fingertips so you can focus on running your campaign.Email us the type of bloggers you want to reach out for your marketing campaign at anuj@feedspot.com . We'll share blogger's data in an Excel or CSV format.Email us
2. Pharma in Brief
Blog https://www.pharmainbrief.com/ + Follow Blog
Pharma in Brief is written by Norton Rose Fulbright litigation and regulatory lawyers covering topics such as patent and class action disputes, drug advertising & reimbursement, and compliance with Health Canada's governing laws and guidelines. Stay up-to-date with legal and regulatory developments affecting the pharmaceutical industry.MORE Email ****@nortonrosefulbright.com
Facebook Followers 6.6KTwitter Followers 19.3K Since Mar 2014 Domain Authority 13 Read Now Get Email Contact
3. Kluwer Patent Blog » Pharma
Blog https://patentblog.kluweriplaw.com/category/p.. + Follow Blog
Pharma, an abbreviation commonly used for the pharmaceutical industry, discovers, develops, produces and markets drugs or pharmaceutical drugs for use as medication. Stay up to date on case law and developments in IP Law on the pharma industry via Kluwer Patent Blog.MORE Email ****@bristows.com
Facebook Followers 32.8KTwitter Followers 18.3K Since Oct 2015 Domain Authority 48 Read Now Get Email Contact
4. IPWatchdog » Pharmaceutical
Blog https://ipwatchdog.com/tag/pharmaceuticals/ + Follow Blog
IPWatchdog is the leading IP law publication on the Internet. Our focus is on the law and policy of patents, technology, and innovation. Find updates on Pharma Patent from IPWatchdog.com.
Email ****@ipwatchdog.com
Facebook Followers 5.3KTwitter Followers 19.4K Since Apr 2008 Domain Authority 71 Read Now Get Email Contact
5. DrugPatentWatch Blog
Blog https://www.drugpatentwatch.com/blog/ + Follow Blog
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Business intelligence on pharmaceutical and biologic drugs - patents, generics, pricing, sales, litigation, and more. Make Better Decisions with DrugPatentWatch.MORE Email ****@DrugPatentWatch.com
Facebook Followers 250Twitter Followers 15.2K Domain Authority 58 Read Now Get Email Contact
6. Pharma IP Circle
Blog http://pharmaipcircle.blogspot.com/ + Follow Blog
A niche blog dedicated to 'Drug Patent Litigation' decisions from all over the world.
Since Apr 2012 Domain Authority 5 Read Now Get Email Contact
7. BioPharma Law Group, PLLC Blog
Blog http://www.biopharmalaw.com/blog + Follow Blog
Innovators in life sciences, BioPharma Law Group's team of professionals has the industry knowledge and in-house experience to identify critical issues and provide strategic solutions that address the client's legal and business needs.MORE Email ****@biopharmalaw.com
Twitter Followers 31 Since Jun 2017 Domain Authority 2 Read Now Get Email Contact
8. Foley & Lardner LLP Blog » PharmaPatents
Blog https://www.foley.com/en/insights/blogs/pharm.. + Follow Blog
PharmaPatents is an online resource for up-to-date information to help you devise strategies that will maximize the value of your intellectual property in the chemical, biotech, and pharmaceutical fields. Building and maintaining a strong global patent portfolio requires an understanding of the latest legal developments affecting your industry. Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing clients and their industries.MORE Email ****@foley.com
Facebook Followers 2.2KTwitter Followers 9.4K Domain Authority 60 Read Now Get Email Contact
Pharma Patent Bloggers
Blogger Name | Designation | Blog Link | |
---|---|---|---|
Courtenay C. Brinckerhoff | Contributor | foley.com | |
Naho Ebata (abe | Contributor | kluweriplaw.com | |
Ikubo | Contributor | kluweriplaw.com | |
Amp; Katayama) | Contributor | kluweriplaw.com | |
Mami Hi | Contributor | kluweriplaw.com | |
Boris Malakhov (lidings) | Contributor | kluweriplaw.com | |
Charlotte Jacobsen (gibson | Contributor | kluweriplaw.com | |
Dunn | Contributor | kluweriplaw.com | |
Kevin M. Finson (wolters Kluwer Legal | Contributor | kluweriplaw.com | |
Magnus Dahlman (gulliksson) | Contributor | kluweriplaw.com | |
Matthieu Dhenne (ipsilon) | Contributor | kluweriplaw.com | |
Selin Sinem Erciyas (gün + Partners) | Contributor | kluweriplaw.com | |
Aysel Kor | Contributor | kluweriplaw.com | |
Roberto Rodrigues Pinho (licks Attorneys) | Contributor | kluweriplaw.com | |
Felipe | Contributor | kluweriplaw.com | |
Denise | Contributor | kluweriplaw.com | |
Gabriel Di Blasi (di Blasi | Contributor | kluweriplaw.com | |
Parente | Contributor | kluweriplaw.com | |
Ivan Do | Contributor | kluweriplaw.com | |
Oswin Ridderbusch (vossius | Contributor | kluweriplaw.com | |
Rik Lambers (brinkhof) | Contributor | kluweriplaw.com | |
Rica | Contributor | kluweriplaw.com | |
Rachel Mumby (bristows) | Contributor | kluweriplaw.com | |
Chloe Dickson (bristows) | Contributor | kluweriplaw.com | |
George Basharis (wolters Kluwer Legal | Contributor | kluweriplaw.com | |
Kate O’sullivan (bristows) | Contributor | kluweriplaw.com | |
John Greiss | Contributor | pharmainbrief.com | |
Paul Jorgensen | Contributor | pharmainbrief.com | |
Kristin Wall | Contributor | pharmainbrief.com | |
William Chalmers | Contributor | pharmainbrief.com | |
Christopher A. Guerreiro | Contributor | pharmainbrief.com | |
Chelsea Nimmo | Contributor | pharmainbrief.com | |
Fortunat Nadima Nadima | Contributor | pharmainbrief.com | |
Anna Wilkinson | Contributor | pharmainbrief.com | |
Dav | Contributor | pharmainbrief.com | |
David Yi | Contributor | pharmainbrief.com | |
Allyson Whyte Nowak | Contributor | pharmainbrief.com | |
Sarah Pennington | Contributor | pharmainbrief.com | |
Christian Cawthorn | Contributor | pharmainbrief.com | |
Stephen Lam | Contributor | pharmainbrief.com | |
Caroline Henri | Contributor | pharmainbrief.com | |
Pardeep Heir | Contributor | pharmainbrief.com | |
Julia Won | Contributor | pharmainbrief.com | |
Roya Ghafele | Contributor | ipwatchdog.com | |
Patrick Kilbride | Contributor | ipwatchdog.com | |
La'cee Conley | Contributor | ipwatchdog.com | |
Hans Sauer | Contributor | ipwatchdog.com | |
Aaron R. Wininger | Contributor | ipwatchdog.com | |
Fatih Mercan | Contributor | foley.com | |
Yogeeta B. Jadhav | Contributor | foley.com |